Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects
Clinical trial NCT06326723 · COMPLETED
Trial details
- NCT number
- NCT06326723
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-04
- Primary completion
- 2023-12-24
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.